CO5200767A1 - Nueva forma cristalina de la sal disodica del acido n-[4-[2-(2- amino 4,7-dihidro-4-oxo-3h-pirrolo [2,3-d]- pirimidin-5-il] etil] benzoil]-l- glutamico y procedimiento para el mismo - Google Patents
Nueva forma cristalina de la sal disodica del acido n-[4-[2-(2- amino 4,7-dihidro-4-oxo-3h-pirrolo [2,3-d]- pirimidin-5-il] etil] benzoil]-l- glutamico y procedimiento para el mismoInfo
- Publication number
- CO5200767A1 CO5200767A1 CO00062633A CO00062633A CO5200767A1 CO 5200767 A1 CO5200767 A1 CO 5200767A1 CO 00062633 A CO00062633 A CO 00062633A CO 00062633 A CO00062633 A CO 00062633A CO 5200767 A1 CO5200767 A1 CO 5200767A1
- Authority
- CO
- Colombia
- Prior art keywords
- glutamic
- oxo
- amino
- pirimidin
- pirrolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15025499P | 1999-08-23 | 1999-08-23 | |
US18496400P | 2000-02-25 | 2000-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5200767A1 true CO5200767A1 (es) | 2002-09-27 |
Family
ID=26847471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00062633A CO5200767A1 (es) | 1999-08-23 | 2000-08-22 | Nueva forma cristalina de la sal disodica del acido n-[4-[2-(2- amino 4,7-dihidro-4-oxo-3h-pirrolo [2,3-d]- pirimidin-5-il] etil] benzoil]-l- glutamico y procedimiento para el mismo |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1212325A2 (fr) |
AU (1) | AU6890800A (fr) |
CO (1) | CO5200767A1 (fr) |
PE (1) | PE20010489A1 (fr) |
WO (1) | WO2001014379A2 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4846158B2 (ja) * | 2000-02-25 | 2011-12-28 | イーライ リリー アンド カンパニー | N−[4−[2−(2−アミノ−4,7−ジヒドロ−4−オキソ−3H−ピロロ[2,3−d]ピリミジン−5−イル)エチル]ベンゾイル]−L−グルタミン酸の新規結晶形およびその製造方法 |
US20050208139A1 (en) | 2004-03-22 | 2005-09-22 | Ascend Therapeutics, Inc. | Chemically stable compositions of 4-hydroxy tamoxifen |
KR101101443B1 (ko) | 2006-08-14 | 2012-01-03 | 시코르, 인크. | 페메트렉세드의 중간체의 제조 방법 |
EP1934226A2 (fr) | 2006-08-14 | 2008-06-25 | Sicor, Inc. | Diacide de pemetrexed de haute pureté et ses procédés de préparation |
DE602007010894D1 (de) * | 2006-08-14 | 2011-01-13 | Sicor Inc | Tellungsverfahren dafür |
EP1943252B1 (fr) | 2006-08-14 | 2010-12-22 | Sicor, Inc. | Procédés de préparation de sels pharmaceutiquement acceptables lyophilisés de diacide de pemetrexed |
EP2129674A2 (fr) * | 2007-04-03 | 2009-12-09 | Dr. Reddy's Laboratories Ltd. | Formes solides de pemetrexed |
CN101417998B (zh) | 2007-10-24 | 2012-10-24 | 重庆医药工业研究院有限责任公司 | 一种培美曲塞盐的纯化方法 |
US20090181990A1 (en) * | 2007-12-23 | 2009-07-16 | Patel Nileshkumar S | Stable amorphous form of pemetrexed disodium |
ME02273B (me) * | 2008-06-06 | 2016-02-20 | Boehringer Ingelheim Int | Farmaceutska kombinacija |
EP2334685A4 (fr) * | 2008-09-08 | 2011-10-26 | Reddys Lab Ltd Dr | Disodium de pemetrexed amorphe |
WO2010030598A2 (fr) * | 2008-09-11 | 2010-03-18 | Dr. Reddy's Laboratories Limited | Formulations pharmaceutiques comprenant du pemetrexed |
CN101684121B (zh) | 2008-09-22 | 2013-04-03 | 重庆医药工业研究院有限责任公司 | 培美曲塞二酸的新晶型及其制备方法 |
TW201118098A (en) * | 2009-08-13 | 2011-06-01 | Reddy S Lab Liimited Dr | Processes for preparing pemetrexed |
CN102050825B (zh) * | 2009-11-05 | 2014-12-17 | 上海创诺制药有限公司 | 制备培美曲塞二钠2.5水结晶的方法 |
US9174991B2 (en) | 2009-11-24 | 2015-11-03 | Azad Pharmaceutical Ingredients Ag | Crystalline form of pemetrexed disodium |
UA105580C2 (uk) * | 2010-08-02 | 2014-05-26 | Неон Лабораторіс Лтд. | Спосіб одержання діалкілпеметрекседу високої чистоти |
KR101308767B1 (ko) | 2011-01-20 | 2013-12-31 | 에스티팜 주식회사 | 고 순도 페메트렉세드 디에틸 에스테르의 제조방법 및 이 방법을 포함하는 페메트렉세드 이나트륨염의 제조방법 |
EP2675808A4 (fr) * | 2011-02-15 | 2014-07-09 | Hetero Research Foundation | Procédé d'obtention de pemetrexed disodique |
US9051322B2 (en) | 2011-03-23 | 2015-06-09 | Scinopharm Taiwan, Ltd. | Process for the production of a pemetrexed salt |
EP2688888B1 (fr) * | 2011-03-25 | 2017-06-14 | Scinopharm Taiwan, Ltd. | Procédé pour la production de disodium pémétrexed |
EP2909208A4 (fr) * | 2012-10-17 | 2016-07-13 | Shilpa Medicare Ltd | Procédé pour préparer du dipotassium de pémetrexed et ses hydrates |
US20150359898A1 (en) | 2013-02-06 | 2015-12-17 | Cipla Limited | Pemetrexed Complexes and Pharmaceutical Compositions Containing Pemetrexed Complexes |
WO2014185797A1 (fr) | 2013-05-17 | 2014-11-20 | Instytut Farmaceutyczny | Procédé pour la préparation de pemetrexed disodique amorphe de haute pureté et formes cristallines de l'acide n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)éthyl]benzoyl]-l-glutamique |
WO2015008221A1 (fr) | 2013-07-16 | 2015-01-22 | Dr. Reddy’S Laboratories Limited | Nouvelles formes cristallines de sels de trométhamine de pemetrexed |
NZ630292A (en) * | 2013-11-25 | 2015-02-27 | Shilpa Medicare Ltd | Process for crystalline pemetrexed dipotassium salt |
CN103784454B (zh) * | 2014-01-22 | 2015-11-18 | 海南锦瑞制药有限公司 | 一种含有培美曲塞二钠化合物的药物组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200001220T2 (tr) * | 1997-09-26 | 2001-05-21 | Eli Lilly And Company | Antifolatlar yapmak için yararlı işlemler ve aramaddeler. |
-
2000
- 2000-08-15 WO PCT/US2000/020777 patent/WO2001014379A2/fr not_active Application Discontinuation
- 2000-08-15 EP EP00957261A patent/EP1212325A2/fr not_active Withdrawn
- 2000-08-15 AU AU68908/00A patent/AU6890800A/en not_active Abandoned
- 2000-08-22 PE PE2000000850A patent/PE20010489A1/es not_active Application Discontinuation
- 2000-08-22 CO CO00062633A patent/CO5200767A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20010489A1 (es) | 2001-04-27 |
WO2001014379A2 (fr) | 2001-03-01 |
EP1212325A2 (fr) | 2002-06-12 |
WO2001014379A3 (fr) | 2001-09-07 |
AU6890800A (en) | 2001-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5200767A1 (es) | Nueva forma cristalina de la sal disodica del acido n-[4-[2-(2- amino 4,7-dihidro-4-oxo-3h-pirrolo [2,3-d]- pirimidin-5-il] etil] benzoil]-l- glutamico y procedimiento para el mismo | |
PE20011082A1 (es) | UNA NUEVA FORMA CRISTALINA DEL ACIDO N-[4-[2-(2-AMINO-4,7-DIHIDRO-4-OXO-3H-PIRROLO[2,3-d] PIRIMIDIN-5-IL)ETIL]BENZOIL]-L-GLUTAMICO Y PROCEDIMIENTO PARA SU PREPARACION | |
TERASHIMA et al. | Studies on antiulcer agents. IV. Antiulcer effects of 2-benzylthio-5, 6, 7, 8-tetrahydro-4 (3H)-quinazolinones and related compounds | |
RU2001122164A (ru) | Кристаллическая кальциевая соль бис[(е)-7-[4-(4-фторфенил)-6-изопропил-2-[метил(метилсульфонил)амино]- пиримидин-5-ил]-(3r,5s)-3,5-дигидроксигепт-6-еновой кислоты] | |
BR0109577A (pt) | Composto, processo para preparar o mesmo, composição farmacêutica, uso de um composto, e, método para tratar cânceres em um animal de sangue quente | |
EA200500721A1 (ru) | Пиримидины, ингибирующие chk, pdk и акт, их получение и применение в качестве лекарственных средств | |
MX9427A (es) | Acidos alcandifosfonicos substituidos y procedimiento para su preparacion | |
BR1100931A (pt) | Compostos derivados de aril-heteroaril carbinóis, processos para a preparação dos compostos, composições farmacêuticas, e, uso dos compostos derivados de aril-heteroaril carbinóis | |
CO5251405A1 (es) | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il- 4-o-tolil-piridin-3-il)-isobutiramida | |
TR200000786T2 (tr) | Vitronektin reseptör antagonisti | |
GB0401336D0 (en) | Organic compounds | |
CO5180567A1 (es) | Sal polimor | |
BR0308018A (pt) | Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo | |
AU666422B2 (en) | Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds | |
IL195837A0 (en) | 4-amino-3-arylamino-6-arylpyrazolo[3,4-d] | |
AR044175A1 (es) | Compuestos de cefemo | |
EA200000924A2 (ru) | СПОСОБ ПОЛУЧЕНИЯ ПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОН-3-ПИРИДИЛСУЛЬФОНИЛЬНЫХ СОЕДИНЕНИЙ И ИХ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ | |
PT968189E (pt) | Processo para a preparacao de acidos nicotinicos | |
NO982107D0 (no) | Fremstilling av et salt av klavulansyre | |
CO5170530A1 (es) | Procedimietno para preparar derivados de 10,11-metanobenzosuberano | |
YU11494A (sh) | Postupak za dobijanje derivata piperazinilkamforsulfonila kao antagonista oksitocina | |
SE8705196L (sv) | Pyrimidinderivat | |
CO5080739A1 (es) | Compuestos antibacterianos de cefalosporinas de 7-acilamino- 3-(amino-guanidina ciclica) metileno utiles como productos farmaceuticos y procesos para su produccion | |
ES8500742A1 (es) | Procedimiento para la preparacion de derivados de acido fenilacetico | |
DE69402058D1 (de) | Perhydroisoindol-derivate, deren herstellung und die sie behaltende pharmazeutische zusammenfassungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |